Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing ?? T Cells, ?? T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.

ABSTRACT: ?? T cells, ?? T cells, and innate lymphoid cells (ILCs) are capable of producing interleukin (IL)-17A, IL-17F, and IL-22. Among these three families of lymphocytes, it is emerging that ?? T cells are, at least in rodents, the main source of these key pro-inflammatory cytokines. ?? T cells were implicated in multiple inflammatory and autoimmune diseases, including psoriasis, experimental autoimmune encephalomyelitis and uveitis, colitis, and rheumatoid arthritis. Recent findings pointed toward a central role of ?? T cells in the pathogenesis of spondyloarthritis (SpA), a group of inflammatory rheumatic diseases affecting the axial skeleton. SpA primarily manifests as inflammation and new bone formation at the entheses, which are connecting tendons or ligaments with bone. In SpA patients, joint inflammation is frequently accompanied by extra-articular manifestations, such as inflammatory bowel disease or psoriasis. In humans, genome-wide association studies could link the IL-23/IL-17 cytokine axis to SpA. Accordingly, antibodies targeting IL-23/IL-17 for SpA treatment already showed promising results in clinical studies. However, the contribution of IL-17-producing ?? T cells to SpA pathogenesis is certainly not an open-and-shut case. Indeed, the cell types that are chiefly involved in local inflammation in human SpA still remain largely unclear. Some studies focusing on blood or synovium from SpA patients reported augmented IL-17-producing and IL-23 receptor-expressing ?? T cells, but other cell types might contribute as well. Here, we summarize the current understanding of how ?? T cells, ?? T cells, and ILCs contribute to the pathogenesis of human and experimental SpA.

SUBMITTER: Reinhardt A 

PROVIDER: S-EPMC5996894 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature